Chondroprotective effects of CDK4/6 inhibition via enhanced ubiquitin-dependent degradation of JUN in synovial fibroblasts

OBJECTIVE: Targeting synovial fibroblasts (SF) using a cyclin-dependent kinase (CDK) 4/6 inhibitor (CDKI) could be a potent therapy for RA via inhibition of proliferation and MMP-3 production. This study was designed to elucidate the mechanism of chondroprotective effects on SFs by CDK 4/6 inhibitio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosoya, Tadashi, Saito, Tetsuya, Baba, Hiroyuki, Tanaka, Nao, Noda, Seiji, Komiya, Youji, Tagawa, Yasuhiro, Yamamoto, Akio, Mizoguchi, Fumitaka, Kawahata, Kimito, Miyasaka, Nobuyuki, Kohsaka, Hitoshi, Yasuda, Shinsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Basic Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348617/
https://www.ncbi.nlm.nih.gov/pubmed/34849618
http://dx.doi.org/10.1093/rheumatology/keab874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348617/
https://www.ncbi.nlm.nih.gov/pubmed/34849618
http://dx.doi.org/10.1093/rheumatology/keab874

Ejemplares similares